RNA-Based Therapeutic Strategies for Inherited Retinal Dystrophies

被引:8
作者
Garanto, Alejandro [1 ,2 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands
来源
RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY | 2019年 / 1185卷
关键词
RNA-based therapies; RNA editing; Antisense oligonucleotides; Trans-splicing; U1snRNA; siRNA; Cas13; ANTISENSE OLIGONUCLEOTIDE; MESSENGER-RNA; U1; SNRNA; FOMIVIRSEN; THERAPIES; RHODOPSIN; MUTATION; RESCUE; DESIGN; SAFETY;
D O I
10.1007/978-3-030-27378-1_12
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Inherited retinal dystrophies (IRDs) are genetic diseases affecting 1 in every 3000 individuals worldwide. Nowadays, more than 250 genes have been associated with different forms of IRD. In the last decade, it has been shown that gene therapy is a promising approach to correct the genetic defects underlying IRD. In fact, voretigene neparvovec-rzyl (Luxturna (TM)), the first commercialized gene therapy drug to treat RPE65-associated Leber congenital amaurosis, has opened new venues. However, IRDs are highly heterogeneous at genetic level making the design of novel strategies complicated. Unfortunately, the size of several frequently mutated genes is not suitable for the approved conventional therapeutic viral vectors; therefore, there is an urgent need for the development of alternatives, such as those targeting the pre-mRNA. In this mini-review, the potential of RNA-based strategies for IRDs is discussed.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 41 条
[11]   Promising and delivering gene therapies for vision loss [J].
Carvalho, Livia S. ;
Vandenberghe, Luk H. .
VISION RESEARCH, 2015, 111 :124-133
[12]   Antisense oligonucleotides: From design to therapeutic application [J].
Chan, JHP ;
Lim, SH ;
Wong, WSF .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2006, 33 (5-6) :533-540
[13]   Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect [J].
Cideciyan, Artur V. ;
Jacobson, Samuel G. ;
Drack, Arlene V. ;
Ho, Allen C. ;
Charng, Jason ;
Garafalo, Alexandra V. ;
Roman, Alejandro J. ;
Sumaroka, Alexander ;
Han, Ian C. ;
Hochstedler, Maria D. ;
Pfeifer, Wanda L. ;
Sohn, Elliott H. ;
Taiel, Magali ;
Schwartz, Michael R. ;
Biasutto, Patricia ;
de Wit, Wilma ;
Cheetham, Michael E. ;
Adamson, Peter ;
Rodman, David M. ;
Platenburg, Gerard ;
Tome, Maria D. ;
Balikova, Irina ;
Nerinckx, Fanny ;
De Zaeytijd, Julie ;
Van Cauwenbergh, Caroline ;
Leroy, Bart P. ;
Russell, Stephen R. .
NATURE MEDICINE, 2019, 25 (02) :225-+
[14]   Antisense Oligonucleotide (AON)-based Therapy for Leber Congenital Amaurosis Caused by a Frequent Mutation in CEP290 [J].
Collin, Rob W. J. ;
den Hollander, Anneke I. ;
van der Velde-Visser, Saskia D. ;
Bennicelli, Jeannette ;
Bennett, Jean ;
Cremers, Frans P. M. .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2012, 1 :e14
[15]   RNA editing with CRISPR-Cas13 [J].
Cox, David B. T. ;
Gootenberg, Jonathan S. ;
Abudayyeh, Omar O. ;
Franklin, Brian ;
Kellner, Max J. ;
Joung, Julia ;
Zhang, Feng .
SCIENCE, 2017, 358 (6366) :1019-1027
[16]   Spliceosome-Mediated Pre-mRNA trans-Splicing Can Repair CEP290 mRNA [J].
Dooley, Scott J. ;
McDougald, Devin S. ;
Fisher, Krishna J. ;
Bennicelli, Jeanette L. ;
Mitchell, Lloyd G. ;
Bennett, Jean .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2018, 12 :294-308
[17]   Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 Models [J].
Dulla, Kalyan ;
Aguila, Monica ;
Lane, Amelia ;
Jovanovic, Katarina ;
Parfitt, David A. ;
Schulkens, Iris ;
Chan, Hee Lam ;
Schmidt, Iris ;
Beumer, Wouter ;
Vorthoren, Lars ;
Collin, Rob W. J. ;
Garanto, Alejandro ;
Duijkers, Lonneke ;
Brugulat-Panes, Anna ;
Semo, Ma'ayan ;
Vugler, Anthony A. ;
Biasutto, Patricia ;
Adamson, Peter ;
Cheetham, Michael E. .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2018, 12 :730-740
[18]   Antisense Oligonucleotide-Based Splice Correction of a Deep-Intronic Mutation in CHM Underlying Choroideremia [J].
Garanto, Alejandro ;
Van der Velde-Visser, Saskia D. ;
Cremers, Frans P. M. ;
Collin, Rob W. J. .
RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2018, 1074 :83-89
[19]   In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery [J].
Garanto, Alejandro ;
Chung, Daniel C. ;
Duijkers, Lonneke ;
Corral-Serrano, Julio C. ;
Messchaert, Muriel ;
Xiao, Ru ;
Bennett, Jean ;
Vandenberghe, Luk H. ;
Collin, Rob W. J. .
HUMAN MOLECULAR GENETICS, 2016, 25 (12) :2552-2563
[20]   Fomivirsen - Clinical pharmacology and potential drug interactions [J].
Geary, RS ;
Henry, SP ;
Grillone, LR .
CLINICAL PHARMACOKINETICS, 2002, 41 (04) :255-260